Home › Compare › DOCRF vs EQR

DOCRF vs EQR: Dividend Comparison 2026

DOCRF yields 9756.10% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DOCRF wins by $43230381229833840.00M in total portfolio value
10 years
DOCRF
DOCRF
● Live price
9756.10%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43230381229833840.00M
Annual income
$42,375,942,331,967,610,000,000.00
Full DOCRF calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — DOCRF vs EQR

📍 DOCRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDOCRFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DOCRF + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
DOCRF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DOCRF
Annual income on $10K today (after 15% tax)
$829,268.29/yr
After 10yr DRIP, annual income (after tax)
$36,019,550,982,172,465,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, DOCRF beats the other by $36,019,550,982,172,465,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DOCRF + EQR for your $10,000?

DOCRF: 50%EQR: 50%
100% EQR50/50100% DOCRF
Portfolio after 10yr
$21615190614916920.00M
Annual income
$21,187,971,165,983,804,000,000.00/yr
Blended yield
98.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

DOCRF
No analyst data
Altman Z
-7.4
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DOCRF buys
0
EQR buys
0
No recent congressional trades found for DOCRF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDOCRFEQR
Forward yield9756.10% ✓4.73%
Annual dividend / share$2.00$2.77 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$43230381229833840.00M ✓$40.5K
Annual income after 10y$42,375,942,331,967,610,000,000.00 ✓$3,819.61
Total dividends collected$43173501257510792.00M ✓$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: DOCRF vs EQR ($10,000, DRIP)

YearDOCRF PortfolioDOCRF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$986,310$975,609.76$11,248$547.57+$975.1K → DOCRF
2$90,985,578$89,930,226.22$12,701$666.53+$90.97M → DOCRF
3$7,850,557,226$7,753,202,657.96$14,405$814.59+$7850.54M → DOCRF
4$633,609,188,528$625,209,092,296.54$16,413$999.84+$633609.17M → DOCRF
5$47,836,734,147,594$47,158,772,315,868.44$18,795$1,232.92+$47836734.13M → DOCRF
6$3,378,690,702,500,742$3,327,505,396,962,816.50$21,639$1,527.95+$3378690702.48M → DOCRF
7$223,260,494,299,726,370$219,645,295,248,050,560.00$25,057$1,903.80+$223260494299.70M → DOCRF
8$13,803,319,479,942,732,000$13,564,430,751,042,025,000.00$29,197$2,385.87+$13803319479942.70M → DOCRF
9$798,541,026,043,208,800,000$783,771,474,199,670,000,000.00$34,250$3,008.70+$798541026043208.75M → DOCRF
10$43,230,381,229,833,840,000,000$42,375,942,331,967,610,000,000.00$40,467$3,819.61+$43230381229833840.00M → DOCRF

DOCRF vs EQR: Complete Analysis 2026

DOCRF — Stock

CloudMD Software & Services Inc. operates as a healthcare technology company in North America. The company operates through three segments: Clinic Services & Pharmacies, Digital Health Services, and Enterprise Health Solutions. It offers enterprise health solutions, including mental health support, healthcare navigation, rehabilitation and assessments, education, and absence management and occupational health. The company also provides billing and electronic medical records solutions; MyHealthAccess, a patient portal that enables online appointment booking and virtual care visits; and Health and Wellness, a real time intervention and prevention platform, which enables an automated real time inquiry of disparate data sources in various domains, identify indicators, and compute risk scores. In addition, it offers iMD platform for peer-reviewed educational resources; telemedicine services; and VisionPros, an online vision care platform that provides contact lenses to customers. Further, the company operates a network of hybrid medical and rehabilitation clinics; and medical clinics for family practice and patient care on-site, as well as retails prescription drugs, over-the-counter drugs, and other front store items through two pharmacies. Additionally, it provides patient support programs that offers navigation and support for holistic disease management and clinical treatment outcomes; and pharmaceutical logistic services, including drug distribution and patient navigation assistance, as well as real-time universal disease management software. The company was formerly known as Premier Health Group Inc. and changed its name to CloudMD Software & Services Inc. in February 2020. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.

Full DOCRF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this DOCRF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DOCRF vs SCHDDOCRF vs JEPIDOCRF vs ODOCRF vs KODOCRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.